SLC7A5 and cancer: Besides LAT1, this inhibitor is also able to block the activity of other leucine-accepting transporters and the authors conclude that LAT1-mediated amino acid transport alone might have limited impact on anchorage-dependent cancer cell proliferation in tumors [117].